Biotechnology Market Research Reports
Sort By
| Title | Published | Price | Buy Now |
|---|---|---|---|
| Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Ephrin Type A Recept... |
Jan 2019 | $ 1250 | |
| Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Epithelial Sodium Channel (ENaC) Inhibit... |
Jan 2019 | $ 1250 | |
| Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2019
By Delve Insight
"Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Estrogen Receptor Beta Partial Agonist devel... |
Jan 2019 | $ 1250 | |
| Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor II (Prothrombin) Inhibitor development. Th... |
Jan 2019 | $ 1250 | |
| Factor IX - Pipeline Insight, 2019
By Delve Insight
"Factor IX - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor IX development. The report provides detailed coverage of the pipel... |
Jan 2019 | $ 1250 | |
| Factor IX A Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor IX A Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor IX A Inhibitor development. The report provides detail... |
Jan 2019 | $ 1250 | |
| Factor VIIa Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor VIIa Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor VIIa Inhibitor development. The report provides detail... |
Jan 2019 | $ 1250 | |
| Factor VIII Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor VIII Inhibitor - Pipeline Insights, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Factor VIII Inhibitor. A detailed picture of the pipeline landscape is provided with summation of ... |
Jan 2019 | $ 1250 | |
| Farnesoid X Receptor (FXR) Agonist - Pipeline Insight, 2019
By Delve Insight
"Farnesoid X Receptor (FXR) Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Farnesoid X Receptor (FXR) Agonist development. ... |
Jan 2019 | $ 1250 | |
| Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fatty Acid Amide Hydrolase (FAAH) Inhib... |
Jan 2019 | $ 1250 | |
| Fatty Acid Synthase (FAS) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fatty Acid Synthase (FAS) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fatty Acid Synthase (FAS) Inhibitor development... |
Jan 2019 | $ 1250 | |
| Fc-Gamma Receptor Antagonist - Pipeline Insight, 2019
By Delve Insight
"Fc-Gamma Receptor Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fc-Gamma Receptor Antagonist development. The report p... |
Jan 2019 | $ 1250 | |
| Fibroblast Activation Protein (FAP or Seprase) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fibroblast Activation Protein (FAP or Seprase) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fibroblast Activation Prot... |
Jan 2019 | $ 1250 | |
| Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fibroblast Growth Factor (FGF) Inhibitor d... |
Jan 2019 | $ 1250 | |
| Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fibroblast Growth Factor 1 (FGF-1) Inh... |
Jan 2019 | $ 1250 | |
| Focal Adhesion Kinase (FAK) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Focal Adhesion Kinase (FAK) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Focal Adhesion Kinase (FAK) Inhibitor develop... |
Jan 2019 | $ 1250 | |
| GABA Transaminase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"GABA Transaminase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "GABA Transaminase Inhibitor development. The report pro... |
Jan 2019 | $ 1250 | |
| GABAA Modulators - Pipeline Insight, 2019
By Delve Insight
"GABAA Modulators - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "GABAA Modulators development. The report provides detailed coverag... |
Jan 2019 | $ 1250 | |
| GABAB Agonist - Pipeline Insight, 2019
By Delve Insight
"GABAB Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "GABAB Agonist development. The report provides detailed coverage of t... |
Jan 2019 | $ 1250 | |
| Galectin Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Galectin Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Galectin Inhibitor development. The report provides detailed cov... |
Jan 2019 | $ 1250 | |
| Gamma Secretase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Gamma Secretase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Gamma Secretase Inhibitor development. The report provide... |
Jan 2019 | $ 1250 | |
| Ghrelin Receptor Agonist - Pipeline Insight, 2019
By Delve Insight
"Ghrelin Receptor Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Ghrelin Receptor Agonist development. The report provides ... |
Jan 2019 | $ 1250 | |
| Glucagon Receptor Antagonist - Pipeline Insight, 2019
By Delve Insight
"Glucagon Receptor Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Glucagon Receptor Antagonist development. The report p... |
Jan 2019 | $ 1250 | |
| Glucocorticoid Receptor (GR) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Glucocorticoid Receptor (GR) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Glucocorticoid Receptor (GR) Antagonist dev... |
Jan 2019 | $ 1250 | |
| Glucosylceramide Synthase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Glucosylceramide Synthase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Glucosylceramide Synthase Inhibitor development... |
Jan 2019 | $ 1250 |